Implanet S.A. (ALIMP.PA)

EUR 0.11

(1.33%)

Gross Profit Summary of Implanet S.A.

Implanet S.A.'s latest annual gross profit in 2023 was 3.13 Million EUR , down -19.82% from previous year.
Implanet S.A.'s latest quarterly gross profit in 2024 Q2 was 1.8 Million EUR , down 0.0% from previous quarter.
Implanet S.A. reported a annual gross profit of 3.9 Million EUR in annual gross profit 2022, up 42.45% from previous year.
Implanet S.A. reported a annual gross profit of 2.74 Million EUR in annual gross profit 2021, up 72.02% from previous year.
Implanet S.A. reported a quarterly gross profit of 1.93 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Implanet S.A. reported a quarterly gross profit of 1.38 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of Implanet S.A. (2023 - 2012)

Historical Annual Gross Profit of Implanet S.A. (2023 - 2012)

Year	Gross Profit	Gross Profit Growth
2023	3.13 Million EUR	-19.82%
2022	3.9 Million EUR	42.45%
2021	2.74 Million EUR	72.02%
2020	1.59 Million EUR	-53.94%
2019	3.46 Million EUR	17.68%
2018	2.94 Million EUR	-6.87%
2017	3.15 Million EUR	3.0%
2016	3.06 Million EUR	86.63%
2015	1.64 Million EUR	-23.93%
2014	2.15 Million EUR	98.52%
2013	1.08 Million EUR	-50.11%
2012	2.18 Million EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	1.8 Million EUR	0.0%
2023 Q2	1.93 Million EUR	0.0%
2023 Q4	1.38 Million EUR	0.0%
2023 FY	3.13 Million EUR	-19.82%
2022 Q4	1.86 Million EUR	0.0%
2022 Q2	2.03 Million EUR	0.0%
2022 FY	3.9 Million EUR	42.45%
2021 Q2	1.96 Million EUR	0.0%
2021 FY	2.74 Million EUR	72.02%
2021 Q4	780 Thousand EUR	0.0%
2020 Q2	1.13 Million EUR	0.0%
2020 FY	1.59 Million EUR	-53.94%
2020 Q4	1.76 Million EUR	0.0%
2019 Q4	1.76 Million EUR	0.0%
2019 FY	3.46 Million EUR	17.68%
2019 Q2	1.8 Million EUR	0.0%
2018 FY	2.94 Million EUR	-6.87%
2018 Q2	1.59 Million EUR	0.0%
2018 Q4	1.34 Million EUR	0.0%
2017 Q2	1.73 Million EUR	0.0%
2017 FY	3.15 Million EUR	3.0%
2017 Q4	1.42 Million EUR	0.0%
2016 Q4	1.42 Million EUR	0.0%
2016 FY	3.06 Million EUR	86.63%
2016 Q2	1.64 Million EUR	0.0%
2015 FY	1.64 Million EUR	-23.93%
2015 Q4	856.6 Thousand EUR	0.0%
2015 Q2	786.23 Thousand EUR	0.0%
2014 Q2	1.18 Million EUR	0.0%
2014 Q4	975.31 Thousand EUR	0.0%
2014 FY	2.15 Million EUR	98.52%
2013 FY	1.08 Million EUR	-50.11%
2013 Q4	358.2 Thousand EUR	0.0%
2013 Q2	729.67 Thousand EUR	0.0%
2012 Q2	545.15 Thousand EUR	0.0%
2012 Q4	627.53 Thousand EUR	15.11%
2012 Q1	545.15 Thousand EUR	0.0%
2012 FY	2.18 Million EUR	0.0%
2012 Q3	545.15 Thousand EUR	0.0%
2011 Q4	545.15 Thousand EUR	0.0%

Peer Gross Profit Comparison of Implanet S.A.

Name	Gross Profit	Gross Profit Difference
Affluent Medical SA	-1.2 Million EUR	361.0%
Bluelinea Société Anonyme	-3.84 Million EUR	181.402%
Carmat SA	-30.97 Million EUR	110.113%
Diagnostic Medical Systems S.A.	15.84 Million EUR	80.231%
Euromedis Groupe	3.57 Million EUR	12.308%
Eurobio Scientific Société anonyme	53.96 Million EUR	94.196%
Ikonisys S.A.	255.82 Thousand EUR	-1124.265%
Median Technologies SA	-2.55 Million EUR	222.775%
SpineGuard SA	3.37 Million EUR	7.311%
Theraclion SA	-1.08 Million EUR	389.897%
Euroapi S.A.	164.6 Million EUR	98.097%
Guerbet SA	197.14 Million EUR	98.411%
Ion Beam Applications SA	134.44 Million EUR	97.67%
Koninklijke Philips N.V.	7.44 Billion EUR	99.958%
Sequana Medical NV	548.04 Thousand EUR	-471.482%